Furthermore, the results presented here highlight MAPK14/mapkapk2/mapkapk3 and their interaction with hsa-miR-9 as a possible molecular mechanism involved in the control of GBM progression. This evidence concerns the gene MAPKAPK3 and glioblastoma.